SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-10-019065
Filing Date
2010-04-08
Accepted
2010-04-08 10:44:44
Documents
2
Group Members
BEN T. MORRISDON A. SANDERSJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND II(INSTITUTIONAL), L.P.SIGNET HEALTHCARE PARTNERS, LLCSMH CAPITAL INC.SOF MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 v174504_sc13da.txt SC 13D/A 46742
2 v174504_ex99-1.txt EX-99.1 2197
  Complete submission text file 0001144204-10-019065.txt   51235
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Subject) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40150 | Film No.: 10738976
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 126 E 56TH STREET 28TH FL NEW YORK NY 10022
Business Address 126 EAST 56TH STREET NEW YORK NY 10022 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A